Institutional members access full text with Ovid®

Share this article on:

Intravenous Smart Pump Drug Library Compliance: A Descriptive Study of 44 Hospitals

Giuliano, Karen K. PhD, RN*; Su, Wan-Ting MS; Degnan, Daniel D. PharmD, MS, CPPS, FASHP; Fitzgerald, Kristy PharmD, MBA§; Zink, Richard J. MBA; DeLaurentis, Poching PhD

doi: 10.1097/PTS.0000000000000383
Original Article: PDF Only

Background Although intravenous (IV) smart pumps with built-in dose-error reduction systems (DERS) can reduce IV medication administration error, most serious adverse events still occur during IV medication administration. Sources of error include overriding DERS and manually bypassing drug libraries and the DERS.

Methods Our purpose was to use the Regenstrief National Center for Medical Device Informatics data set to better understand IV smart pump drug library and DERS compliance. Our sample consisted of 12 months of data from 7 hospital systems, 44 individual hospitals, and descriptive data from the American Hospital Directory (AHD) for 2015. The aims of the study were (1) to determine whether there are differences in IV smart pump drug library compliance between hospital systems and (2) to provide a broad descriptive overview of relevant trends related to IV smart pump compliance.

Results For aim 1, we found 3 significant relationships among the 7 hospital systems: systems 3 (P < 0.001), 6 (P = 0.003), and 7 (P = 0.002) had significantly higher IV smart compliance as compared with system 4. For aim 2, the number of drug library profiles was positively correlated (P = 0.029) with IV smart pump compliance and the IV smart pump type used was significantly correlated (P = 0.013) with IV smart pump compliance.

Conclusions Our findings support that there are differences in IV smart pump compliance both within and between hospital systems and that IV smart pump type and the number of drug library profiles may be influencing factors. Further research is required to more accurately identify the impact of these factors in this very important area of patient safety.

From the *Yale School of Nursing, Orange, Connecticut; †School of Industrial Engineering, Regenstrief Center for Healthcare Engineering, Purdue University, West Lafayette; ‡Center for Medication Safety Advancement, Purdue University College of Pharmacy, Fishers; §Adventist Health Central Valley Network, Hanford, California; ∥Regenstrief Center for Healthcare Engineering, Purdue University, West Lafayette, Indiana.

Correspondence: Karen K. Giuliano, PhD, RN, Yale School of Nursing, 400 West Campus Drive, Orange, CT 06477 and Hallmark Health System, 170 Governors Ave, Medford, MA 02155 (e-mail: kkgiuliano96@gmail.com).

The author discloses no conflict of interest.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved